Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)

The summary for the Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional): The purpose of this Funding Opportunity Announcement (FOA) is to support applications from Small Business Concerns (SBCs) to perform rigorous analytical validation of candidate biomarker measures or endpoints in a manner that is consistent with FDA guidelines. Analytical validation establishes that the performance characteristics of the biomarker measurement or endpoint are acceptable for its intended use.
Federal Grant Title: Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-18-549
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.853
CFDA Descriptions: Information not provided
Current Application Deadline: September 7th, 2020
Original Application Deadline: September 7th, 2020
Posted Date: December 22nd, 2017
Creation Date: December 22nd, 2017
Archive Date: October 13th, 2020
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: December 22nd, 2017
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see funding announcement for eligibility
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-18-549.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Ne...
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Ne...
Biomarkers Discovery In Parkinsonism (U01 Clinical Trial Optional)
NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
Research Program Award (R35 Clinical Trial Optional)
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
Diabetes Research Centers (P30)
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional)
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional)
Enhancing Data Management and Sharing in NIEHS-Funded Research Grants (Admin Supp Clinical...
Understanding the Glycemic Profile of Pregnancy - Biostatistics Research Center (U01 Clini...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com